https://doi.org/10.1007/s00280-021-04385-0
W
Wei Luo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
113
Papers
2.0K
Citations
23
h-index
47
i10-index
Wei Luo is an academic researcher from Jiangsu University. The author has contributed to research in topics: Immune Cell Function and Interaction & Cancer Immunotherapy and Biomarkers & T-cell and B-cell Immunology. The author has an h-index of 23, co-authored 97 publications.
Papers by this author
worksCurcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota
2022 · Cancer Chemotherapy and Pharmacology · 40 citations
Circulating CD8+ T-cell repertoires reveal the biological characteristics of tumors and clinical responses to chemotherapy in breast cancer patients
2018 · Cancer Immunology Immunotherapy · 31 citations
https://doi.org/10.1007/s00262-018-2213-1
Programmed cell death protein-1 (PD-1) protects liver damage by suppressing IFN-γ expression in T cells in infants and neonatal mice
2021 · BMC Pediatrics · 21 citations
https://doi.org/10.1186/s12887-021-02794-x
Significant Difference of Immune Cell Fractions and Their Correlations With Differential Expression Genes in Parkinson’s Disease
2021 · Frontiers in Aging Neuroscience · 18 citations
https://doi.org/10.3389/fnagi.2021.686066
Human induced-T-to-natural killer cells have potent anti-tumour activities
2022 · Biomarker Research · 18 citations
https://doi.org/10.1186/s40364-022-00358-4
Development of genetically engineered iNKT cells expressing TCRs specific for the M. tuberculosis 38-kDa antigen
2015 · Journal of Translational Medicine · 14 citations
https://doi.org/10.1186/s12967-015-0502-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat